Growth Metrics

Guardant Health (GH) Enterprise Value (2017 - 2025)

Historic Enterprise Value for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$580.0 million.

  • Guardant Health's Enterprise Value rose 3524.64% to -$580.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$580.0 million, marking a year-over-year increase of 3524.64%. This contributed to the annual value of -$840.0 million for FY2024, which is 2812.31% up from last year.
  • Latest data reveals that Guardant Health reported Enterprise Value of -$580.0 million as of Q3 2025, which was up 3524.64% from -$629.1 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Enterprise Value ranged from a high of -$580.0 million in Q3 2025 and a low of -$1.9 billion during Q1 2021
  • Its 5-year average for Enterprise Value is -$1.0 billion, with a median of -$958.0 million in 2022.
  • Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 29635.1% in 2021, then skyrocketed by 5071.82% in 2022.
  • Over the past 5 years, Guardant Health's Enterprise Value (Quarter) stood at -$932.7 million in 2021, then fell by 8.41% to -$1.0 billion in 2022, then dropped by 15.57% to -$1.2 billion in 2023, then increased by 28.12% to -$840.0 million in 2024, then soared by 30.95% to -$580.0 million in 2025.
  • Its last three reported values are -$580.0 million in Q3 2025, -$629.1 million for Q2 2025, and -$698.6 million during Q1 2025.